Deepinder Goyal hits back at critics of his ₹85,000 Temple wearable: 'We didn't make any medical claim'
The Zomato founder says Temple is a fitness and AI device, not a medical one, and that he expects no more than 1% of its sales to come from India.

Temple, the wearable from Deepinder Goyal's startup, has drawn questions over its ₹85,000 price, its science and the way it is positioned as a fitness and AI device. Medical professionals have asked for evidence, especially for its claim to track changes in blood flow to the brain.